lb
Live tape.Join the lounge
Overview
Fundamentals
Valuation
Events
Relationships
Profile

Research with context.

A clearer way to explore the market.

Create an accountContact the team
lb/longbrunch

Market signals, research, watchlists, and alerts in one workspace.

Follow the signal.

ProductPricingFAQ
Data coverageMethodologyDisclosuresContact
© 2026 Longbrunch. All rights reserved.
longbrunch/
KYMR/Research

Financial Statements

KYMERA THERAPEUTICS INC · Equity
Partial coverage
IncomeBalance SheetCash Flow
AnnualQuarterly

Latest available snapshot

2026-07-31 · not a complete statement series

Revenue$34.37M
EPS-3.58

Cash Flow

Quarterly periods

Financial trajectoryPending integration
CoveragePending integration
CurrencyUSD
UnitAs reported
RestatementsData pending
Cash Flow · quarterly structure preview
MetricSelected periodComparisonGrowth
Operating cash flowData pendingPendingPending
Capital expenditureData pendingPendingPending
Free cash flowData pendingPendingPending
Financing cash flowData pendingPendingPending
Investing cash flowData pendingPendingPending
Cash changeData pendingPendingPending